Annual EBITDA
$5.08 M
+$10.51 M+193.43%
December 31, 2023
Summary
- As of February 7, 2025, XTNT annual EBITDA is $5.08 million, with the most recent change of +$10.51 million (+193.43%) on December 31, 2023.
- During the last 3 years, XTNT annual EBITDA has risen by +$3.75 million (+282.15%).
- XTNT annual EBITDA is now at all-time high.
Performance
XTNT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.69 M
-$855.00 K-46.59%
September 30, 2024
Summary
- As of February 7, 2025, XTNT quarterly EBITDA is -$2.69 million, with the most recent change of -$855.00 thousand (-46.59%) on September 30, 2024.
- Over the past year, XTNT quarterly EBITDA has dropped by -$11.26 million (-131.37%).
- XTNT quarterly EBITDA is now -131.37% below its all-time high of $8.57 million, reached on September 30, 2023.
Performance
XTNT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$8.91 M
-$11.26 M-478.10%
September 30, 2024
Summary
- As of February 7, 2025, XTNT TTM EBITDA is -$8.91 million, with the most recent change of -$11.26 million (-478.10%) on September 30, 2024.
- Over the past year, XTNT TTM EBITDA has dropped by -$14.50 million (-259.21%).
- XTNT TTM EBITDA is now -259.21% below its all-time high of $5.59 million, reached on September 30, 2023.
Performance
XTNT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XTNT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +193.4% | -131.4% | -259.2% |
| 3 y3 years | +282.1% | -137.0% | -3627.2% |
| 5 y5 years | +109.5% | -2590.7% | -1226.2% |
XTNT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +193.4% | -131.4% | at low | -259.2% | at low |
| 5 y | 5-year | at high | +193.4% | -131.4% | at low | -259.2% | at low |
| alltime | all time | at high | +109.5% | -131.4% | +94.9% | -259.2% | +83.3% |
Xtant Medical Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.69 M(+46.6%) | -$8.91 M(-478.1%) |
| Jun 2024 | - | -$1.83 M(-26.4%) | $2.36 M(-34.6%) |
| Mar 2024 | - | -$2.49 M(+31.8%) | $3.60 M(-29.0%) |
| Dec 2023 | $5.08 M(-193.4%) | -$1.89 M(-122.1%) | $5.08 M(-9.3%) |
| Sep 2023 | - | $8.57 M(-1558.2%) | $5.59 M(-224.1%) |
| Jun 2023 | - | -$588.00 K(-42.3%) | -$4.51 M(-8.0%) |
| Mar 2023 | - | -$1.02 M(-25.7%) | -$4.90 M(-9.8%) |
| Dec 2022 | -$5.43 M(+115.4%) | -$1.37 M(-10.2%) | -$5.43 M(-4.4%) |
| Sep 2022 | - | -$1.53 M(+55.6%) | -$5.68 M(+7.4%) |
| Jun 2022 | - | -$982.00 K(-36.6%) | -$5.29 M(+19.1%) |
| Mar 2022 | - | -$1.55 M(-4.3%) | -$4.44 M(+76.2%) |
| Dec 2021 | -$2.52 M(-289.9%) | -$1.62 M(+42.7%) | -$2.52 M(+954.4%) |
| Sep 2021 | - | -$1.14 M(+740.7%) | -$239.00 K(-111.1%) |
| Jun 2021 | - | -$135.00 K(-136.5%) | $2.16 M(-9.1%) |
| Mar 2021 | - | $370.00 K(-44.0%) | $2.38 M(+78.9%) |
| Dec 2020 | $1.33 M(+67.7%) | $661.00 K(-47.7%) | $1.33 M(+14.0%) |
| Sep 2020 | - | $1.26 M(+1461.7%) | $1.17 M(>+9900.0%) |
| Jun 2020 | - | $81.00 K(-111.9%) | $9000.00(-90.5%) |
| Mar 2020 | - | -$678.00 K(-236.1%) | $95.00 K(-88.0%) |
| Dec 2019 | $792.00 K(-101.5%) | $498.00 K(+361.1%) | $791.00 K(-101.5%) |
| Sep 2019 | - | $108.00 K(-35.3%) | -$52.76 M(+0.5%) |
| Jun 2019 | - | $167.00 K(+827.8%) | -$52.52 M(-1.3%) |
| Mar 2019 | - | $18.00 K(-100.0%) | -$53.23 M(-0.3%) |
| Dec 2018 | -$53.36 M(+82.1%) | -$53.05 M(<-9900.0%) | -$53.37 M(+130.2%) |
| Sep 2018 | - | $353.00 K(-165.2%) | -$23.18 M(-7.2%) |
| Jun 2018 | - | -$541.00 K(+343.4%) | -$24.98 M(-13.0%) |
| Mar 2018 | - | -$122.00 K(-99.5%) | -$28.70 M(-0.7%) |
| Dec 2017 | -$29.30 M(<-9900.0%) | -$22.87 M(+1485.0%) | -$28.89 M(+422.4%) |
| Sep 2017 | - | -$1.44 M(-66.2%) | -$5.53 M(+41.1%) |
| Jun 2017 | - | -$4.26 M(+1258.3%) | -$3.92 M(-632.3%) |
| Mar 2017 | - | -$314.00 K(-163.9%) | $736.40 K(+1097.4%) |
| Dec 2016 | $61.40 K | $491.40 K(+192.5%) | $61.50 K(-105.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $168.00 K(-57.0%) | -$1.09 M(-71.9%) |
| Jun 2016 | - | $391.00 K(-139.5%) | -$3.88 M(-30.4%) |
| Mar 2016 | - | -$988.90 K(+49.4%) | -$5.57 M(-21.4%) |
| Dec 2015 | -$7.09 M(+82.0%) | -$661.90 K(-74.7%) | -$7.09 M(-9.5%) |
| Sep 2015 | - | -$2.62 M(+101.4%) | -$7.83 M(+65.7%) |
| Jun 2015 | - | -$1.30 M(-48.1%) | -$4.73 M(+27.5%) |
| Mar 2015 | - | -$2.51 M(+78.5%) | -$3.71 M(-4.9%) |
| Dec 2014 | -$3.90 M(-46.5%) | -$1.40 M(-389.2%) | -$3.90 M(-26.1%) |
| Sep 2014 | - | $485.50 K(-272.2%) | -$5.27 M(-39.7%) |
| Jun 2014 | - | -$282.00 K(-89.5%) | -$8.74 M(-8.7%) |
| Mar 2014 | - | -$2.70 M(-3.1%) | -$9.58 M(+31.4%) |
| Dec 2013 | -$7.29 M(+43.8%) | -$2.78 M(-6.9%) | -$7.29 M(-15.2%) |
| Sep 2013 | - | -$2.99 M(+168.2%) | -$8.59 M(+21.3%) |
| Jun 2013 | - | -$1.11 M(+175.1%) | -$7.08 M(+48.1%) |
| Mar 2013 | - | -$404.90 K(-90.1%) | -$4.78 M(-5.1%) |
| Dec 2012 | -$5.07 M(+365.4%) | -$4.08 M(+176.4%) | -$5.04 M(-0.4%) |
| Sep 2012 | - | -$1.48 M(-224.5%) | -$5.06 M(-11.6%) |
| Jun 2012 | - | $1.19 M(-279.1%) | -$5.72 M(-19.6%) |
| Mar 2012 | - | -$662.50 K(-83.9%) | -$7.12 M(+712.8%) |
| Dec 2011 | -$1.09 M(-93.6%) | -$4.10 M(+91.6%) | -$875.90 K(-62.7%) |
| Sep 2011 | - | -$2.14 M(+920.4%) | -$2.35 M(-73.7%) |
| Jun 2011 | - | -$209.90 K(-103.8%) | -$8.92 M(-9.1%) |
| Mar 2011 | - | $5.58 M(-200.1%) | -$9.82 M(-40.0%) |
| Dec 2010 | -$17.14 M(+490.2%) | -$5.58 M(-36.0%) | -$16.35 M(+36.0%) |
| Sep 2010 | - | -$8.72 M(+688.9%) | -$12.03 M(+147.2%) |
| Jun 2010 | - | -$1.10 M(+15.7%) | -$4.87 M(+17.0%) |
| Mar 2010 | - | -$955.00 K(-23.5%) | -$4.16 M(+29.4%) |
| Dec 2009 | -$2.90 M(>+9900.0%) | -$1.25 M(-19.9%) | -$3.21 M(+59.1%) |
| Sep 2009 | - | -$1.56 M(+291.8%) | -$2.02 M(+359.1%) |
| Jun 2009 | - | -$397.60 K(+3957.1%) | -$439.90 K(+940.0%) |
| Mar 2009 | - | -$9800.00(-82.0%) | -$42.30 K(+30.2%) |
| Dec 2008 | -$15.80 K | -$54.40 K(-348.4%) | -$32.50 K(-248.4%) |
| Sep 2008 | - | $21.90 K | $21.90 K |
FAQ
- What is Xtant Medical Holdings annual EBITDA?
- What is the all time high annual EBITDA for Xtant Medical Holdings?
- What is Xtant Medical Holdings annual EBITDA year-on-year change?
- What is Xtant Medical Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for Xtant Medical Holdings?
- What is Xtant Medical Holdings quarterly EBITDA year-on-year change?
- What is Xtant Medical Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for Xtant Medical Holdings?
- What is Xtant Medical Holdings TTM EBITDA year-on-year change?
What is Xtant Medical Holdings annual EBITDA?
The current annual EBITDA of XTNT is $5.08 M
What is the all time high annual EBITDA for Xtant Medical Holdings?
Xtant Medical Holdings all-time high annual EBITDA is $5.08 M
What is Xtant Medical Holdings annual EBITDA year-on-year change?
Over the past year, XTNT annual EBITDA has changed by +$10.51 M (+193.43%)
What is Xtant Medical Holdings quarterly EBITDA?
The current quarterly EBITDA of XTNT is -$2.69 M
What is the all time high quarterly EBITDA for Xtant Medical Holdings?
Xtant Medical Holdings all-time high quarterly EBITDA is $8.57 M
What is Xtant Medical Holdings quarterly EBITDA year-on-year change?
Over the past year, XTNT quarterly EBITDA has changed by -$11.26 M (-131.37%)
What is Xtant Medical Holdings TTM EBITDA?
The current TTM EBITDA of XTNT is -$8.91 M
What is the all time high TTM EBITDA for Xtant Medical Holdings?
Xtant Medical Holdings all-time high TTM EBITDA is $5.59 M
What is Xtant Medical Holdings TTM EBITDA year-on-year change?
Over the past year, XTNT TTM EBITDA has changed by -$14.50 M (-259.21%)